Premier Alternatives

Micron Biomedical

Atlanta, GA · Founded 2009 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines. Micron Biomedical is based in Atlanta, GA and was founded in 2009. It was valued at $105 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $32 million across 3 recorded rounds; the latest was a $15 million early-stage round in Dec 2024.

PMV mark · valuation
$105.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$32.0M
Last round
Early Stage VC
Dec 2024

Micron Biomedical key facts

as of Oct 2026
  • Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines.
  • Micron Biomedical is valued at approximately $105.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $32.0M across 3 recorded rounds; the latest was Early Stage VC ($15.0M) in Dec 2024.
  • Notable investors include National Institutes of Health, Gates Foundation, J2 Ventures, Global Health Investment Corporation, BARDA — 12 tracked in total.
  • Micron Biomedical has filed 3 Form Ds with the SEC since 2022, most recently Dec 2024 ($15.0M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$105.0M

Valued at $105.0M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Micron Biomedical with a free account
  • ·The complete investor list: 12 names
  • ·Watch Micron Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Micron Biomedical funding rounds

3 rounds
Dec 2024Early Stage VC$15.0MSEC filing▮
Apr 2023Seed Round$3.0MSEC filing▮
Nov 2022Early Stage VC$14.0MSEC filing▮
Full funding history →

Micron Biomedical valuation

Micron Biomedical was valued at $105 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Micron Biomedical raised?

Micron Biomedical has raised $32 million across 3 recorded rounds since 2022. The largest was a $3 million seed round in Apr 2023; the most recent was a $15 million early-stage round in Dec 2024.

Micron Biomedical has filed 3 Form Ds with the SEC since 2022, most recently in Dec 2024 ($15 million sold to 3 investors).

Micron Biomedical investors

12 investors are on record for Micron Biomedical, including National Institutes of Health, Gates Foundation, J2 Ventures and Global Health Investment Corporation. The early-stage round in Dec 2024 drew 3 investors.

About Micron Biomedical

Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines. The company's microneedle technology provides enhanced protective and therapeutic effects, patient compliance and simplified administration, enabling researchers to offer conventional vaccine delivery.

Sector
Healthcare
HQ
Atlanta, GA, United States
Founded
2009
Employees
25
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.